Cathleen Haase-Kohn

7PUBLICATIONS
23CO-AUTHORS
Biologically active moleculesPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 12, 2026
An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin.

|Apr 01, 2026
Radioiodination of Two Carborane-Based Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation.

Jonas Schädlich, Martin Ullrich, Cathleen Haase-Kohn

|Jul 12, 2025
Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2).

Jens Pietzsch, Magali Toussaint, Cornelius Kurt Donat

|Oct 14, 2022
Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells.

Florian Brandt, Martin Ullrich, Verena Seifert

|May 06, 2022
Deuteration versus ethylation - strategies to improve the metabolic fate of an 18F-labeled celecoxib derivative.

Markus Laube, Cemena Gassner, Christin Neuber

|Apr 23, 2022
The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells.

Julia Aepler, Johanna Wodtke, Robert Wodtke

Pageof 2

Frequent Collaborators

7 joint publications

Jens Pietzsch

6 joint publications

Markus Laube

4 joint publications

Robert Wodtke

4 joint publications

Martin Ullrich